Stonepine Capital Management, LLC Quant / Systematic

Name: Stonepine Capital Management, LLC Q1 2016 13F Filing | 13F Explorer
Creator: Stonepine Capital Management, LLC
Published: 2016-05-11

Location: Bend, OR

CIK: 0001440771 · Show all filings

Period: Q1 2016 (← Previous) (Next →)

Filing Date: May 11, 2016

Total Value: $84.79M (97.3% shares, 2.7% debt)

Holdings (19)

— SCICLONE PHARMACEUTICALS INC 26.6%

Value $22.54M Shares 2,048,638 Est. Cost $9.97 Unrealized —

VNDA VANDA PHARMACEUTICALS INC 20.4%

Value $17.29M Shares 2,068,297 Est. Cost $9.85 Unrealized -16.7%

VCEL VERICEL CORP 9.8%

Value $8.309M Shares 1,417,939 Est. Cost $2.25 Unrealized +24.5%

— PAIN THERAPEUTICS INC 9.3%

Value $7.873M Shares 3,530,401 Est. Cost $1.75 Unrealized —

— TOBIRA THERAPEUTICS INC 8.0%

Value $6.814M Shares 832,977 Est. Cost $10.05 Unrealized —

— CUTERA INC 4.9%

Value $4.188M Shares 372,300 Est. Cost $11.66 Unrealized —

— SAGENT PHARMACEUTICALS INC 4.8%

Value $4.053M Shares 333,065 Est. Cost $15.91 Unrealized —

— PERNIX THERAPEUTICS HOLDINGS 4.0%

Value $3.377M Shares 3,215,861 Est. Cost $2.52 Unrealized —

— PERNIX THERAPEUTICS HOLDINGS 2.7%

Value $2.318M Shares 6,000,000 Est. Cost $0.39 Unrealized —

— CTI BIOPHARMA CORP 2.3%

Value $1.989M Shares 3,743,340 Est. Cost $1.23 Unrealized —

— ZELTIQ Aesthetics, Inc. 2.2%

Value $1.901M Shares 70,000 Est. Cost $27.16 Unrealized —

— DERMA SCIENCES INC 1.9%

Value $1.574M Shares 507,799 Est. Cost $4.57 Unrealized —

— RECRO PHARMA INC 1.7%

Value $1.414M Shares 236,874 Est. Cost $7.46 Unrealized —

— BioSpecifics Technologies Corp. 1.1%

Value $893K Shares 25,637 Est. Cost $34.83 Unrealized —

— Raptor Pharmaceuticals Corp. 0.1%

Value $92,000 Shares 20,000 Est. Cost $4.60 Unrealized —

— Sucampo Pharmaceuticals, Inc. 0.1%

Value $57,000 Shares 5,228 Est. Cost $10.90 Unrealized —

ANIP ANI Pharmaceuticals, Inc. 0.1%

Value $56,000 Shares 1,650 Est. Cost $33.92 Unrealized 0.0%

— INSYS Therapeutics, Inc. 0.0%

Value $32,000 Shares 2,000 Est. Cost $16.00 Unrealized —

— BioDelivery Sciences International, Inc. 0.0%

Value $28,000 Shares 8,523 Est. Cost $3.29 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	SCICLONE PHARMACEUTICALS INC	2,048,638	$22.54M	26.6%	$9.97	—	COM	80862K104
VNDA	VANDA PHARMACEUTICALS INC	2,068,297	$17.29M	20.4%	$9.85	-16.7%	COM	921659108
VCEL	VERICEL CORP	1,417,939	$8.309M	9.8%	$2.25	+24.5%	COM	92346J108
—	PAIN THERAPEUTICS INC	3,530,401	$7.873M	9.3%	$1.75	—	COM	69562K100
—	TOBIRA THERAPEUTICS INC	832,977	$6.814M	8.0%	$10.05	—	COM	88883P101
—	CUTERA INC	372,300	$4.188M	4.9%	$11.66	—	COM	232109108
—	SAGENT PHARMACEUTICALS INC	333,065	$4.053M	4.8%	$15.91	—	COM	786692103
—	PERNIX THERAPEUTICS HOLDINGS	3,215,861	$3.377M	4.0%	$2.52	—	COM	71426V108
—	PERNIX THERAPEUTICS HOLDINGS	6,000,000	$2.318M	2.7%	$0.39	—	DEBT	71426VAJ7
—	CTI BIOPHARMA CORP	3,743,340	$1.989M	2.3%	$1.23	—	COM	12648L106
—	ZELTIQ Aesthetics, Inc.	70,000	$1.901M	2.2%	$27.16	—	COM	98933Q108
—	DERMA SCIENCES INC	507,799	$1.574M	1.9%	$4.57	—	COM	249827502
—	RECRO PHARMA INC	236,874	$1.414M	1.7%	$7.46	—	COM	75629F109
—	BioSpecifics Technologies Corp.	25,637	$893K	1.1%	$34.83	—	COM	090931106
—	Raptor Pharmaceuticals Corp.	20,000	$92,000	0.1%	$4.60	—	COM	75382F106
—	Sucampo Pharmaceuticals, Inc.	5,228	$57,000	0.1%	$10.90	—	COM	864909106
ANIP	ANI Pharmaceuticals, Inc.	1,650	$56,000	0.1%	$33.92	0.0%	COM	00182C103
—	INSYS Therapeutics, Inc.	2,000	$32,000	0.0%	$16.00	—	COM	45824V209
—	BioDelivery Sciences International, Inc.	8,523	$28,000	0.0%	$3.29	—	COM	09060J106